Nishant Agrawal to Radiotherapy Dosage
This is a "connection" page, showing publications Nishant Agrawal has written about Radiotherapy Dosage.
Connection Strength
0.284
-
E1308: Phase II Trial of Induction Chemotherapy Followed by Reduced-Dose Radiation and Weekly Cetuximab in Patients With HPV-Associated Resectable Squamous Cell Carcinoma of the Oropharynx- ECOG-ACRIN Cancer Research Group. J Clin Oncol. 2017 Feb 10; 35(5):490-497.
Score: 0.135
-
Management of early-stage laryngeal cancer. Otolaryngol Clin North Am. 2008 Aug; 41(4):757-69, vi-vii.
Score: 0.075
-
Dose and Volume De-Escalation for Human Papillomavirus-Positive Oropharyngeal Cancer is Associated with Favorable Posttreatment Functional Outcomes. Int J Radiat Oncol Biol Phys. 2020 07 15; 107(4):662-671.
Score: 0.042
-
External-beam radiotherapy for differentiated thyroid cancer locoregional control: A statement of the American Head and Neck Society. Head Neck. 2016 Apr; 38(4):493-8.
Score: 0.031